Engineers Gate Manager’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-295,287
Closed -$4.72M 2211
2025
Q2
$4.72M Sell
295,287
-109,888
-27% -$1.96M 0.06% 404
2025
Q1
$7.87M Buy
405,175
+159,202
+65% +$3.35M 0.13% 202
2024
Q4
$5.42M Buy
245,973
+69,444
+39% +$1.34M 0.09% 297
2024
Q3
$2.97M Buy
176,529
+107,600
+156% +$1.6M 0.06% 461
2024
Q2
$824K Buy
68,929
+27,235
+65% +$304K 0.02% 986
2024
Q1
$462K Buy
41,694
+2,574
+7% +$26.3K 0.01% 1232
2023
Q4
$339K Buy
+39,120
New +$304K 0.01% 1388

Other funds holding CLBT

Engineers Gate Manager's CLBT Position: Q3 2025 in Review

Engineers Gate Manager sold out of Cellebrite (CLBT) in Q3 2025, closing a stake of 295,287 shares — an estimated $4.72M sold.

Engineers Gate Manager first reported a position in CLBT in Q4 2023 and held it in 7 quarters. The position peaked at $7.87M in Q1 2025. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2025.

  • Engineers Gate Manager reported no remaining Cellebrite position as of Q3 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 295,287 Cellebrite shares in Q3 2025, an estimated $4.72M.
  • Engineers Gate Manager first reported a position in Cellebrite in Q4 2023 and held it in 7 quarters.
  • Engineers Gate Manager's Cellebrite position peaked at $7.87M in Q1 2025.
  • 197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2025.

Based on Engineers Gate Manager's 13F filing for Q3 2025, filed 14 Nov 2025.